Skip to main content
. Author manuscript; available in PMC: 2017 Jan 17.
Published in final edited form as: J Bone Miner Res. 2015 May;30(5):855–868. doi: 10.1002/jbmr.2417

Table 1.

RANKL Transgene is Capable of Supporting Normal B-Cell and T-Cell Development

RANKL+/+ RANKL−/− RANKL−/−;Tg719
Bone marrow
  PreProB cells (B220+CD24lowBP1) (%) 3.6 ± 0.6 × 3.2 ± 0.7
  ProB cells (B220+CD24+BP1) (%) 3.8 ± 1.0 × 3.4 ± 0.9
  PreB cells (B220+CD24+BP1+) (%) 9.4 ± 1.3 × 8.6 ± 3.0
  Immature B cells (B220+CD24+IgM+IgD) (%) 14.7 ± 2.9 × 12.6 ± 3.0
  Transitional B cells (B220+CD24+IgMhighIgDlow) (%) 3.3 ± 0.6 × 2.7 ± 1.0
  Early mature B cells (B220+CD24+IgMhighIgDhigh) (%) 1.0 ± 0.8 × 1.1 ± 0.6
  Late mature B cells (B220+CD24+IgMlowIgDhigh) (%) 1.7 ± 1.4 × 1.9 ± 0.9
  CD3+ T cells (%) 1.9 ± 0.4 × 1.7 ± 0.6
Spleen
  B220+IgM+ B cells (%) 26.6 ± 3.2 15.0 ± 4.8* 28.6 ± 3.5
  B220+IgD+ B cells (%) 40.6 ± 3.8 16.2 ± 5.2* 43.3 ± 4.7
  CD3+ T cells (%) 35.6 ± 5.8 37.4 ± 3.3 32.1 ± 3.1
  CD4+ T cells (%) 21.9 ± 4.7 22.9 ± 3.3 19.4 ± 1.1
  CD8+ T cells (%) 14.2 ± 1.4 15.0 ± 1.4 13.2 ± 1.9

Values are mean ± SD of 3 to 4 animals per genotype. All animals used in the experiments were 6-week-old female littermates. Flow cytometry analysis of the B and T cells in bone marrow and spleen were done after red blood cell lysis.

*

p<0.05 compared to wild-type as evaluated by one-way ANOVA.